Laboratorios Farmaceuticos Rovi Investor Relations Material
Latest events
CMD 2025
Laboratorios Farmaceuticos Rovi
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Laboratorios Farmaceuticos Rovi S.A.
Access all reports
Laboratorios Farmaceuticos Rovi, a pharmaceutical technology company, researches and develops pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers anti-inflammatory medicines; vitamins; analgesics; cosmetics/hygiene products; and/or nutritional supplements for skin health, such as daily cleansing care for oily skin. It also provides respiratory medicines to treat allergic rhinitis, bronchial asthma, pulmonary obstructive disease, pharyngitis, laryngitis, angina pectoris, hypertension heart failure. In addition, the company offers gastroenterology products to treat gastric ulceration and duodenal ulceration; duodenal reflux oesophagitis; hiatal hernia with gastro-oesophageal reflux disease; and peptic ulcer disease.
Key slides for Laboratorios Farmaceuticos Rovi S.A.
Q2 2024
Laboratorios Farmaceuticos Rovi S.A.
CMD 2025
Laboratorios Farmaceuticos Rovi S.A.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
ROVI
Country
🇪🇸 Spain